Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

China · Delayed Price · Currency is CNY

64.16

+0.66 (1.04%)

At close: May 25, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	602.26M	451.87M	388.79M	447.46M	369.44M
Pharmaceuticals Growth	33.28%	16.22%	-13.11%	21.12%	30.85%
Total	602.26M	451.87M	388.79M	447.46M	369.44M
Total Growth	33.28%	16.22%	-13.11%	21.12%	30.85%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	436.00M	288.01M	262.06M	-	-
China Growth	51.38%	9.90%	-	-	-
Export	166.26M	163.87M	126.73M	-	-
Export Growth	1.46%	29.30%	-	-	-
Total	602.26M	451.87M	388.79M	-	-
Total Growth	33.28%	16.22%	-	-	-

Source: S&P Global Market Intelligence.